<DOC>
	<DOCNO>NCT01009216</DOCNO>
	<brief_summary>The objective study assess cerebral spinal fluid ( CSF ) pharmacokinetics plasma/CSF pharmacokinetic/pharmacodynamic relationship ABT-384 healthy male volunteer .</brief_summary>
	<brief_title>A Study ABT-384 Levels Pharmacodynamic Activity Measured Cerebrospinal Fluid</brief_title>
	<detailed_description />
	<criteria>Age 18 55 year Judged condition general good health base result medical history , physical examination , vital sign , laboratory profile 12lead ECG Use protocolprohibited medication within 2 week prior study drug administration . Positive urine drug screen nonprescribed drug abuse include alcohol . Receipt drug depot injection within 30 day prior study drug administration . Receipt investigational product within 6 week prior study drug administration . History significant sensitivity allergy drug . History drug alcohol abuse . Positive test result HAV , HBsAg , HCV HIV . Donation loss 550 mL blood volume receipt blood product within 3 month prior study drug administration . Contraindication lumbar puncture ( e.g. , lumbar scoliosis , coagulopathy , infect skin puncture site ) Current enrollment another clinical study .</criteria>
	<gender>Male</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>55 Years</maximum_age>
	<verification_date>November 2010</verification_date>
	<keyword>Pharmacokinetics</keyword>
	<keyword>Pharmacology</keyword>
	<keyword>Drug Safety</keyword>
	<keyword>Phase 1 Clinical Trials</keyword>
</DOC>